Filing metadata

Accession number
0001209191-22-021487
Form type
Form 4
Filer
Fusion Pharmaceuticals Inc.
CIK
CIK 1805890
Filed
Mar 29, 2022
Reporting period
Mar 25, 2022
Description
Insider transaction

Explore SEC Filings Hub